List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 14 studies with search of: Pyridoxal-5-Phosphate
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Recruiting Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: Pyridoxal 5'-Phosphate;   Drug: Placebo
2 Active, not recruiting Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate
Condition: Primary Hyperoxaluria Type I
Intervention: Drug: Vitamin B 6
3 Completed A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
Conditions: Coronary Artery Bypass Graft Surgery;   Myocardial Ischemia;   Reperfusion Injury
Intervention: Drug: (MC-1) Pyridoxal 5'-phosphate
4 Completed MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
Conditions: Coronary Artery Bypass Graft Surgery;   Myocardial Ischemia;   Reperfusion Injury;   Myocardial Revascularization
Intervention: Drug: (MC-1) Pyridoxal-5’-phosphate
5 Completed MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
Conditions: Diabetes Mellitus Type 2;   Hypertension;   Metabolic Syndrome
Intervention: Drug: pyridoxal-5'-phosphate with and without ACE inhibitor
6 Completed Restoration of Cutaneous Sensorum in Patients With Diabetic Peripheral Neuropathy (DPN) Via Metanx®
Condition: Diabetic Peripheral Neuropathy
Intervention: Drug: Metanx® (Oral L-methylfolate, Methylcobalamin and Pyridoxal 5'-phosphate)
7 Active, not recruiting Metanx® P.L.U.S. Program (Progress Through Learning, Understanding & Support)
Condition: Diabetic Peripheral Neuropathy
Intervention: Other: Metanx® (a medical food)
8 Unknown † Study of Metanx® in Subjects With Type 2 Diabetic Peripheral Neuropathy (DPN)
Condition: Type 2 Diabetic Peripheral Neuropathy (DPN)
Interventions: Other: Metanx (a medical food);   Other: Metanx placebo
9 Recruiting Administrative Claims Analysis of Metanx® in Diabetic Peripheral Neuropathy
Condition: Diabetic Peripheral Neuropathy (DPN)
Interventions: Other: Metanx® (a medical food);   Other: Not treated with Metanx®
10 Completed Protective Effect of Mangafodipir Against Oxaliplatin Neurotoxicity
Conditions: Neurotoxic Disorders;   Cancer
Intervention: Drug: Mangafodipir
11 Active, not recruiting NORVIT and WENBIT - Long-term Follow-up
Conditions: Cancer;   Myocardial Infarction;   Cerebrovascular Stroke
Intervention:
12 Recruiting Mangafodipir as an Adjunct to Percutaneous Coronary Intervention
Condition: Myocardial Infarction
Interventions: Drug: Mangafodipir;   Drug: Placebo
13 Completed Gyrate Atrophy of the Choroid and Retina
Condition: Gyrate Atrophy
Intervention:
14 Completed Mangafodipir as an Adjunct to FOLFOX6 Chemotherapy in Colon Cancer Stage Dukes' C
Conditions: Chemotherapy;   Colon Cancer
Interventions: Drug: Mangafodipir;   Drug: Placebo treatment (0.9% NaCl)

† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services